secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fulgent Genetics, Inc. (FLGT)
CIK:        0001674930
Form:       8-K
Filed at:   2024-08-02T23:59:59+00:00
Accession:  0000950170-24-089587
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fulgent Q2 core revenue $70.2M (+5% YoY); GAAP loss $0.29/share improves EPS guidance
--------------------------------------------------------------------------------

- Total revenue $71.0M; core revenue $70.2M (+5% YoY).
- GAAP net loss $8.7M ($0.29 per share); Non-GAAP income $4.7M ($0.15 per share).
- Adjusted EBITDA loss $727K; cash from ops $4.3M; cash and investments $837.9M.
- Reiterates FY2024 core revenue guidance $280M; improves EPS guidance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1674930/000095017024089587/0000950170-24-089587-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1674930/000095017024089587/flgt-20240802.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-089587

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer